Not recruiting
Adenosquamous cell lung cancer stage III+11
Not recruitingInvestigationalNo placebo
Study on the Accuracy of OWL-EVO1 Test for Diagnosing Lung Cancer in Patients Eligible for Screening or with Suspicious CT Findings
InvestigationalNo placebo
- Disease:Adenosquamous cell lung cancer stage IIIAdenosquamous cell lung cancer+10
- Substances:D5-Ethyl-Beta-D-Glucuronide
Countries:
Czechia
Czechia- Participants:18–64 years · 65+ years
- Substances:D5-Ethyl-Beta-D-Glucuronide
- Sponsor:Owlstone Medical Limited

